Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECIPE: MMF to Reduce Immunogenicity to Pegloticase in Gout
NCT03303989Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in gout, sponsored by University of Alabama at Birmingham. Started Jun 2018; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
gout
Beyond the preview
Go deeper on NCT03303989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303989.